Ruyi Guo
- Hepatology top 5%
- Hepatitis C virus research 3
-
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 4
-
- interferon and immune responses 2
- Immunotherapy and Immune Responses 2
-
- Dermatology and Skin Diseases 2
-
- Clostridium difficile and Clostridium perfringens research 2
-
- Video Surveillance and Tracking Methods 2
- Cited by
- HepatologyEpidemiologyImmunology
- Journals
- Clinical and Vaccine Immunology (2 papers)Medicine (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Ruyi Guo
18 papers receiving 334 citations
Peers
Comparison fields: 5 of 72
- Hepatology 146
- Epidemiology 197
- Immunology 89
- Cancer Research 37
- Pharmacology 18
Countries citing papers authored by Ruyi Guo
This map shows the geographic impact of Ruyi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyi Guo more than expected).
Fields of papers citing papers by Ruyi Guo
This network shows the impact of papers produced by Ruyi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyi Guo. The network helps show where Ruyi Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruyi Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 21 | |
| 9 | 2019 | 7 | |
| 10 | 2019 | 6 | |
| 11 | 2018 | 39 | |
| 12 | 2016 | 17 | |
| 13 | 2015 | 30 | |
| 14 | 2015 | 28 | |
| 15 | [Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis]. | 2015 | 1 |
| 16 | 2013 | 32 | |
| 17 | 2013 | 18 | |
| 18 | 2013 | 34 | |
| 19 | 2012 | 5 | |
| 20 | 2010 | 75 |
About Ruyi Guo
Ruyi Guo is a scholar working on Hepatology, Toxicology and Epidemiology, having authored 20 papers that have together received 336 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (3 papers), interferon and immune responses (2 papers), Dermatology and Skin Diseases (2 papers), Immunotherapy and Immune Responses (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Video Surveillance and Tracking Methods (2 papers). The work is most often cited by research in Hepatology (146 citations), Epidemiology (197 citations) and Immunology (89 citations). Ruyi Guo has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Zhijun Su, Xueping Yu, Yong Deng, Desong Ming, Huatang Zhang, Zhiyin Huang, Jun Zhang, Yixin Chen, Anthony E. T. Yeo and An Li. Their work appears in journals such as Clinical and Vaccine Immunology, Medicine, Journal of Gastroenterology and Hepatology, Materials and Structures and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.